日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study

对至少接受过一种预防性治疗失败的高频发作性偏头痛患者进行erenumab疗效的全面评估:EMBRACE研究

Paiva da Silva Lima, Gabriel; Rao, Renata; Szabó, Gyöngyi; Szklener, Sebastian; Tassorelli, Cristina; Nastaj, Marcin; Chou, Denise E; Khodavirdi, Ani C; Chehrenama, Mahan; Zhu, Yineng; Bhatia, Ajay K; Dodick, David W

Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study

Erenumab治疗成人药物过度使用性头痛的疗效和安全性:一项4期随机安慰剂对照研究的最终结果

Tepper, Stewart J; Dodick, David W; Lanteri-Minet, Michel; Dolezil, David; Gil-Gouveia, Raquel; Lucas, Christian; Piasecka-Stryczynska, Karolina; Szabó, Gyöngyi; Mikol, Daniel D; Chehrenama, Mahan; Chou, Denise E; Liu, Zilu; da Silva Lima, Gabriel Paiva

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial

Erenumab治疗慢性偏头痛中非阿片类药物过度使用性头痛的疗效和安全性:一项4期随机、安慰剂对照试验

Tepper, Stewart J; Dodick, David W; Lanteri-Minet, Michel; Dolezil, David; Gil-Gouveia, Raquel; Lucas, Christian; Piasecka-Stryczynska, Karolina; Szabó, Gyöngyi; Mikol, Daniel D; Chehrenama, Mahan; Chou, Denise E; Yang, Yiping; Paiva da Silva Lima, Gabriel

Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials

依瑞奈单抗治疗各年龄段发作性或慢性偏头痛患者的安全性和耐受性:安慰剂对照试验的汇总分析

Lampl, Christian; Kraus, Viktoria; Lehner, Katrina; Loop, Brett; Chehrenama, Mahan; Maczynska, Zofia; Ritter, Shannon; Klatt, Jan; Snellman, Josefin